KALV Competitors & Alternatives
Compare Kalvista Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
KALV
Main Stock$27.00
Tradestie Score
49
Market Cap
$608.81M
Revenue Growth
0.3%
Analyst Upside
+5.9%
Top Competitors
214 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$91.81
|
$1.55B | - | 35 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$33.76
|
$1.55B | 11.2 | 61 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$33.36
|
$1.55B | - | 43 | Compare |
|
NVAX
Novavax Inc
|
$8.53
|
$1.54B | - | 50 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.73
|
$1.50B | 7.0 | 55 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$20.00
|
$1.50B | - | 38 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$30.29
|
$1.49B | - | 55 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$17.43
|
$1.43B | - | 42 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$11.37
|
$1.42B | - | 43 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.45
|
$1.35B | - | 63 | Compare |
More KALV Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
214 stocks in this industry